Regeneron reports fourth quarter and full year 2024 financial and operating results; initiates quarterly dividend and increases total share repurchase capacity to ~$4.5 billion

Tarrytown, n.y., feb. 04, 2025 (globe newswire) -- regeneron pharmaceuticals, inc. (nasdaq: regn) today announced financial results for the fourth quarter and full year 2024 and provided a business update.
REGN Ratings Summary
REGN Quant Ranking